ErleaDx

ErleaDx is a Singapore-based startup with the mission to develop high-quality diagnostics products for early cancer detection, with a current focus on lung cancer. The company has a patented blood-based biomarker panel that enables the detection of lung cancer with high accuracy at an early stage, allowing for rapid triage and treatment decisions. Emphasizing on Point-Of-Care (POC) diagnostics for lung cancer screening, ErleaDx aims to bring convenience to people by delivering lab-quality results within minutes instead of hours. The company is actively seeking seed investment and welcomes discussions for potential partnerships. With its innovative and integrated device incorporating microfluidic and biosensors expertise, ErleaDx is committed to improving customer satisfaction and patient outcomes, ultimately working towards saving more lives. For inquiries, contact [email protected].